medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2008, Número 3

<< Anterior Siguiente >>

Ann Hepatol 2008; 7 (3)


Model for end stage of liver disease (MELD) is better than the child-pugh score for predicting in-hospital mortality related to esophageal variceal bleeding

Flores-Rendón ÁR, González-González JA, García-Compean D, Maldonado-Garza HJ, Garza-Galindo AA

Idioma: Español
Referencias bibliográficas: 22
Paginas: 230-234
Archivo PDF: 186.29 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Graham D, Smith L. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800-9.

  2. Carbonell N, Pauwells A, Serfaty L, Fourdan O, Lévy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004; 40: 652-9.

  3. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, Pandya P, Sitaraman S, Shen J. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterology 2003; 98: 653-9.

  4. Park DK, Um SH, Lee JW, Lee JB, Kim YS, Park CH, Jin YT, Chun HJ, Lee HS, Lee SW, Choi JH, Kim CD, Ryu HS, Hyun JH. Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices. J Gastroenterol Hepatol 2004; 9: 1042-51.

  5. D’Amico G, De Franchis R: Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38: 599-612.

  6. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh vs MELD. J Hepatol 2005; 42: Suppl (1): 100-7.

  7. Malinchoc M, Kamath PS, Gordon FD, Gordon FD, Peine CJ, Rank J, ter Borg PC. A Model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-71. [PMID: 10733541]

  8. Terra C, Guevara M, Torre A, Gilabert R, Fernández J, Martín-Llahí M, Baccaro ME, Navasa M, Bru C, Arroyo V, Rodés J, Ginès P. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology 2005; 129: 1944-53.

  9. Perkins L, Jeffries M, Patel T. Utility of preoperative scores for predicting morbidity after cholecystectomy in patients with cirrhosis. Clin Gastroenterol Hepatol 2004; 2: 1123-8.

  10. Heuman D, Mihas A. Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answer. Gastroenterology 2003; 125: 992-3.

  11. Dunn W, Jamil LH, Brown L, Wiesner RH, Kim WR, Menon KV, Malinchoc M, Kamath PS, Shah V. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 2005; 41: 353-8.

  12. Srikureja W, Kyulo NL, Runyon B, Hu KQ. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis. J Hepatol 2005; 42: 700-6.

  13. Cholongitas E, Marelli L, Shusang V , Senzolo M, Rolles K, Patch D, Burroughs AK. A systematic review of the performance of the Model for End Stage Liver Disease (MELD) in the setting of liver transplantation. Liver Transpl 2006; 12: 1049-61.

  14. Biggins S, Bambha K. MELD-Based liver allocation: Who is underserved? Semin Liver Dis 2006; 26: 211-20.

  15. Lee JY, Lee JH, Kim SJ, Choi DR, Kim KH, Kim YB, Kim HY, Yoo JY. Comparison of predictive factors related to the mortality and rebleeding caused by variceal bleeding: Child Pugh score, MELD score and Rockall score. Taehan kan Hakhoe Chi 2002; 8: 458-64.

  16. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, Pandya P, Sitaraman S, Shen J. Model for End-Stage Liver Disease (MELD) for predicting mortality in patients with acute variceal bleeding. Hepatology 2002; 35: 1282-4.

  17. Amitrano L, Guardiascione MA, Bennato R, Manguso F, Balzano A. MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices. J Hepatol 2005; 42: 820-5.

  18. Paquet KJ. Prophylactic endoscopic sclerosing treatment of the oesophageal wall in varices: a prospective controlled randomized trial. Endoscopy 1982; 14: 4-5.

  19. De Franchis R. Evolving Consensus in Portal Hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43: 167-76.

  20. Saab S, Landaverde C, Ibrahim AB , Durazo F, Han S, Yersiz H, Farmer DG, Ghobrial RM, Goldstein LI, Tong MJ, Busuttil RW. The MELD score in advanced liver disease: association with clinical portal hypertension and mortality. Exp Clin Transplant 2006; 4: 395-9.

  21. Bernard B, Grange JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta-analysis. Hepatology 1999; 29: 1655-61.

  22. Bambha K, Van Ijperen M, Malinchoc M, et al. Model for End-Stage Liver Disease predicts survival patients with variceal bleeding [abstract]. Gastroenterology 2003 A-665, w1409.




2020     |     www.medigraphic.com